Assembly Biosciences Q2 EPS $(0.20) Beats $(0.65) Estimate, Sales $13.374M Beat $8.599M Estimate
Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.65) by 69.23 percent. This is a 84.96 percent increase over losses of $(1.33) per share
